These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26179604)
21. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Baker JG Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528 [TBL] [Abstract][Full Text] [Related]
22. The use of beta3-adrenergic receptor agonists in the treatment of heart failure. Rasmussen HH; Figtree GA; Krum H; Bundgaard H Curr Opin Investig Drugs; 2009 Sep; 10(9):955-62. PubMed ID: 19705338 [TBL] [Abstract][Full Text] [Related]
23. ROCK2 as a novel target for diabetic cardiomyopathy. Soliman H; Nyamandi V; Hove-Madsen L; MacLeod KM Int J Cardiol; 2020 Jan; 299():206. PubMed ID: 31791538 [No Abstract] [Full Text] [Related]
24. Activation of beta3 adrenergic receptor decreases DNA synthesis in human skin fibroblasts via cyclic GMP/nitric oxide pathway. Furlán C; Sterin-Borda L; Borda E Cell Physiol Biochem; 2005; 16(4-6):175-82. PubMed ID: 16301818 [TBL] [Abstract][Full Text] [Related]
25. Contracting human skeletal muscle maintains the ability to blunt α1 -adrenergic vasoconstriction during KIR channel and Na(+) /K(+) -ATPase inhibition. Crecelius AR; Kirby BS; Hearon CM; Luckasen GJ; Larson DG; Dinenno FA J Physiol; 2015 Jun; 593(12):2735-51. PubMed ID: 25893955 [TBL] [Abstract][Full Text] [Related]
26. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide. Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248 [TBL] [Abstract][Full Text] [Related]
27. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms. Mahmoud AM Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265 [TBL] [Abstract][Full Text] [Related]
28. Blockage of ROS and NF-κB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries. Zhong P; Wu L; Qian Y; Fang Q; Liang D; Wang J; Zeng C; Wang Y; Liang G Biochim Biophys Acta; 2015 Jul; 1852(7):1230-41. PubMed ID: 25736300 [TBL] [Abstract][Full Text] [Related]
29. In-vivo quantification of myocardial Na-K pump rate during beta-adrenergic stimulation of intact pig hearts. Ellingsen O; Sejersted OM; Vengen OA; Ilebekk A Acta Physiol Scand; 1989 Apr; 135(4):493-503. PubMed ID: 2567565 [TBL] [Abstract][Full Text] [Related]
30. NRF2-dependent glutamate-L-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglycemia- induced brain endothelial cell apoptosis. Okouchi M; Okayama N; Alexander JS; Aw TY Curr Neurovasc Res; 2006 Nov; 3(4):249-61. PubMed ID: 17109620 [TBL] [Abstract][Full Text] [Related]
31. [The ability of cells to adjust to the low oxigen content associated with Na,K-ATPase glutationilation]. Petrushanko IIu; Simonenko OV; Burnysheva KM; Klimanova EA; Dergousova EA; Mit'kevich VA; Lopina OD; Makarov AA Mol Biol (Mosk); 2015; 49(1):175-83. PubMed ID: 25916122 [TBL] [Abstract][Full Text] [Related]
32. Noradrenaline increases intracellular glutathione in human astrocytoma U-251 MG cells by inducing glutamate-cysteine ligase protein via β3-adrenoceptor stimulation. Yoshioka Y; Kadoi H; Yamamuro A; Ishimaru Y; Maeda S Eur J Pharmacol; 2016 Feb; 772():51-61. PubMed ID: 26724392 [TBL] [Abstract][Full Text] [Related]
33. Preservation of the positive lusitropic effect of beta-adrenoceptors stimulation in diabetic cardiomyopathy. Amour J; Loyer X; Michelet P; Birenbaum A; Riou B; Heymes C Anesth Analg; 2008 Oct; 107(4):1130-8. PubMed ID: 18806014 [TBL] [Abstract][Full Text] [Related]
34. Redox-dependent regulation of the Na⁺-K⁺ pump: new twists to an old target for treatment of heart failure. Liu CC; Fry NA; Hamilton EJ; Chia KK; Garcia A; Karimi Galougahi K; Figtree GA; Clarke RJ; Bundgaard H; Rasmussen HH J Mol Cell Cardiol; 2013 Aug; 61():94-101. PubMed ID: 23727392 [TBL] [Abstract][Full Text] [Related]
35. Effects of beta3-adrenoceptor activation on the interaction between adrenoceptors and angiotensin II receptors in apolipoprotein E knockout mouse lung. Jiang ZL; Li YF; Song JY; Guo YQ Eur J Pharmacol; 2014 Nov; 742():75-80. PubMed ID: 25220245 [TBL] [Abstract][Full Text] [Related]
36. Further characterization of beta3-adrenoceptors in the guinea pig gastric fundus: stereoselectivity, beta-adrenoceptor alkylation, and structure-activity relationship. Horinouchi T; Koike K Can J Physiol Pharmacol; 2001 Dec; 79(12):985-95. PubMed ID: 11824942 [TBL] [Abstract][Full Text] [Related]
37. Possible mechanism of the negative inotropic effect of alpha1-adrenoceptor agonists in rat isolated left atria after exposure to free radicals. Peters SL; Batink HD; Michel MC; Pfaffendorf M; van Zwieten PA Br J Pharmacol; 1998 Mar; 123(5):952-8. PubMed ID: 9535025 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of rat brain Na+, K+-ATPase activity induced by homocysteine is probably mediated by oxidative stress. Streck EL; Zugno AI; Tagliari B; Franzon R; Wannmacher CM; Wajner M; Wyse AT Neurochem Res; 2001 Nov; 26(11):1195-200. PubMed ID: 11874200 [TBL] [Abstract][Full Text] [Related]
39. Atrial chronotropic reactivity to catecholamines in neonatal rats: Contribution of β-adrenoceptor subtypes. Oliveira ES; Pereira AH; Cardoso AC; Franchini KG; Bassani JWM; Bassani RA Eur J Pharmacol; 2015 Oct; 764():385-394. PubMed ID: 26187314 [TBL] [Abstract][Full Text] [Related]
40. β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling. Galougahi KK; Liu CC; Bundgaard H; Rasmussen HH Trends Cardiovasc Med; 2012 May; 22(4):83-7. PubMed ID: 23040838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]